Compound details
![PDF] The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f160ef061d89b9271c8fb2c2919603cda06de944/6-Figure1-1.png "PDF] The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. | Semantic Scholar")
PDF] The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. | Semantic Scholar
TEDIGLUTIDE ..Glucagon-like peptide 2 (GLP-2) analog; protects small intestinal stem cells from radiation damage. | New Drug Approvals
Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy
Release of glucagon-like peptide (GLP)-2 by L cells. The L cell... | Download Scientific Diagram
Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome | Journal of Pharmacology and Experimental Therapeutics
GLP-2 | gutsandgrowth
Glucagon-like Peptide-2 (GLP-2) (1-33), rat - Echelon Biosciences
Frontiers | Proglucagon-Derived Peptides as Therapeutics
Glucagon.com
Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system - ScienceDirect
Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms | Arteriosclerosis, Thrombosis, and Vascular Biology
Schematic representation of GLP-2 action in the gastrointestinal... | Download Scientific Diagram
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial - The Lancet Gastroenterology & Hepatology
GLP-2 Agonists for Short Bowel Syndrome - ScienceDirect
Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Stock Illustration - Illustration of polypeptide, glp2: 35580175
Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives | SpringerLink
Glucagon-Like Peptide-2 Stimulates S-Phase Entry of Intestinal Lgr5+ Stem Cells - ScienceDirect
Microorganisms | Free Full-Text | GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Current and potential therapeutic targets of glucagon-like peptide-2. | Semantic Scholar
![PDF] GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cfd69eccd23a9c8a10ba8cd828f6dc1685055d28/5-Figure1-1.png "PDF] GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. | Semantic Scholar")
PDF] GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. | Semantic Scholar
Pipeline | R&D
Schematic representation of the action of GLP-2 on the enterocyte or on... | Download Scientific Diagram
Frontiers | GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH
